Allergomedica
Around 30–50% of people believe they are allergic, yet nearly half are misdiagnosed or remain undiagnosed because allergy-like conditions are complex and tests are expensive. Allergomedica delivers allergy and food intolerance tests directly to consumers, offering accurate, easy-to-understand results from the convenience of home at a fraction of the usual cost. Our proprietary test technology provides a significant cost advantage and a defensible moat in the market. To date, we’ve already served almost 30,000 customers in Lithuania and Poland, proving strong demand and scalability.
Amount raised
1.2М Еur
We recently closed our seed round to launch in Germany and the UK. In about 18 months, we plan to raise a Series A to further accelerate growth. We’re now connecting with potential future investors, particularly those with expertise in digital health.

